Acquired lymphedema results in increased levels of pro-inflammatory molecules such as TNFα, IL-6, IL-8, and monocyte chemoattractant protein-1 (MCP-1), which contribute to an increase in the infiltration of pro-inflammatory cells, as well as a decrease in T-regulatory cells involved in the resolution of inflammation [36,37]. This evidence concerns the gene CCL2 and lymphedema.